Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
- PMID: 3487691
- DOI: 10.1016/0024-3205(86)90431-5
Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Abstract
Infusion of MPTP (0.2-0.8 mg/kg) into the right internal carotid artery of monkeys produces toxin-induced injury to the right nigrostriatal pathway with sparing of other dopaminergic neurones on the infused side and with negligible or little injury to the opposite, untreated side. There are contralateral limb dystonic postures, rigidity, and bradykinesia, but the animals are able to eat and maintain health without drug treatment. Spontaneous motor activity is attended by circling towards the injured side, whereas treatment with L-DOPA/-carbidopa or apomorphine stimulates circling towards the intact side. Dopamine and dopamine metabolite levels are normal in the left caudate and putamen, but markedly depressed on the right (MPTP-treated) side. This animal hemiparkinsonian model will be useful in studies of volitional movement control, drug treatments of Parkinson's disease, and functional efficacy of brain tissue implants.
Similar articles
-
Hemiparkinsonism in monkeys following unilateral common carotid artery infusion of MPTP. A study of behavior, biochemistry and histology.Chin Med J (Engl). 1991 Sep;104(9):758-63. Chin Med J (Engl). 1991. PMID: 1935358
-
Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.Brain Res. 1988 Dec 6;474(2):327-32. doi: 10.1016/0006-8993(88)90446-5. Brain Res. 1988. PMID: 3264746
-
Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.Eur J Pharmacol. 1988 May 20;150(1-2):59-66. doi: 10.1016/0014-2999(88)90750-9. Eur J Pharmacol. 1988. PMID: 3261249
-
Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.Neurochirurgie. 1991;37(6):377-82. Neurochirurgie. 1991. PMID: 1780015 Review.
-
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.J Neural Transm Suppl. 1986;20:11-39. J Neural Transm Suppl. 1986. PMID: 3091760 Review.
Cited by
-
Chronic high-frequency stimulation therapy in hemiparkinsonian rhesus monkeys using an implanted human DBS system.Neurol Sci. 2013 May;34(5):707-14. doi: 10.1007/s10072-012-1117-7. Epub 2012 May 24. Neurol Sci. 2013. PMID: 22622869
-
Detecting rhythmic spiking through the power spectra of point process model residuals.bioRxiv [Preprint]. 2024 Mar 25:2023.09.08.556120. doi: 10.1101/2023.09.08.556120. bioRxiv. 2024. Update in: J Neural Eng. 2024 Aug 05;21(4). doi: 10.1088/1741-2552/ad6188. PMID: 38586036 Free PMC article. Updated. Preprint.
-
Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys.Ann Nucl Med. 1995 Aug;9(3):119-23. doi: 10.1007/BF03165037. Ann Nucl Med. 1995. PMID: 8534583
-
Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys.Cell Transplant. 2008;17(4):417-25. Cell Transplant. 2008. PMID: 18522244 Free PMC article.
-
No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease.PLoS One. 2012;7(2):e31439. doi: 10.1371/journal.pone.0031439. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359591 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources